Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 51.41 M57.22 M51.51 M47.95 M 208.08 M Research & development ———— — Operating income -7.4 M-27.48 M-36.72 M-36.38 M -107.98 M Non-Operating Income, Total ———— — Interest expense, net of interest capitalized 17.04 M15.69 M21.77 M19.99 M 74.49 M Non-Operating Income, excl. Interest Expenses ———— — Unusual income/expense ———— — Pretax income -7.4 M-27.48 M-36.72 M-36.38 M -107.98 M Equity in earnings ———— — Taxes -1.67 M-5.01 M39.98 M-2.17 M 31.13 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -5.74 M-22.47 M-76.7 M-34.2 M -139.11 M Discontinued operations ———— — Net income -5.74 M-22.47 M-76.7 M-34.2 M -139.11 M Dilution adjustment 0000 0 Preferred dividends 10 K10 K10 K10 K 40 K Diluted net income available to common stockholders -5.75 M-22.48 M-76.71 M-34.21 M -139.15 M Basic earnings per share (Basic EPS) -0.69-2.71-9.25-4.14 -16.79 Diluted earnings per share (Diluted EPS) -0.69-2.71-9.25-4.14 -16.79 Average basic shares outstanding 8.27 M8.28 M8.3 M8.29 M — Diluted shares outstanding 8.27 M8.28 M8.3 M8.29 M — EBITDA -5.26 M-25.38 M-34.68 M-34.45 M -99.77 M EBIT -7.4 M-27.48 M-36.72 M-36.38 M -107.98 M Cost of revenue 278.12 M298.09 M248.07 M258.93 M 1.08 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 2.14 M2.1 M2.04 M1.93 M 8.21 M